ObsEva R&D Day Showcases Multiple Women’s Health Programs and Outlines Plans for Transition to Commercial Operations

    NEXT STORY
    Nasdaq Welcomes Moderna, Inc. (Nasdaq: MRNA) to The Nasdaq Stock Market
    PREV STORY
    Affimed Announces U.S. Registrational Pathway and Updated Clinical Development Plan for AFM13 at R&D Day
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ContraFect Appoints Lisa Ricciardi as Chief Operating Officer

    YONKERS, N.Y., Oct. 05, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS

    PRESS RELEASE: REGULATED INFORMATION Thursday, 6 September 2018, 07:00 CEST BIOCARTIS ANNOUNCES H1 2018 RESULTS ...

    author_avatar
    NASDAQ Market News

    Stemline Therapeutics Highlights Four ELZONRIS Presentations, Including an Oral Presentation, at the Upcoming ASH Meeting

    NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News